News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,589 Results
Type
Article (45201)
Company Profile (328)
Press Release (697059)
Multimedia
Podcasts (114)
Webinars (18)
Section
Business (215100)
Career Advice (2247)
Deals (37488)
Drug Delivery (121)
Drug Development (84502)
Employer Resources (177)
FDA (17044)
Job Trends (15867)
News (363990)
Policy (34814)
Tag
Academia (2689)
Accelerated approval (11)
Adcomms (29)
Allergies (103)
Alliances (53141)
ALS (115)
Alzheimer's disease (1491)
Antibody-drug conjugate (ADC) (175)
Approvals (17020)
Artificial intelligence (354)
Autoimmune disease (34)
Automation (19)
Bankruptcy (379)
Best Places to Work (12067)
BIOSECURE Act (21)
Biosimilars (136)
Biotechnology (202)
Bladder cancer (95)
Brain cancer (38)
Breast cancer (381)
Cancer (3001)
Cardiovascular disease (236)
Career advice (1877)
Career pathing (33)
CAR-T (196)
CDC (34)
Cell therapy (525)
Cervical cancer (22)
Clinical research (69509)
Collaboration (1091)
Company closure (3)
Compensation (713)
Complete response letters (32)
COVID-19 (2744)
CRISPR (66)
C-suite (346)
Cystic fibrosis (118)
Data (3065)
Decentralized trials (2)
Denatured (36)
Depression (67)
Diabetes (362)
Diagnostics (6695)
Digital health (23)
Diversity (10)
Diversity, equity & inclusion (46)
Drug discovery (148)
Drug pricing (147)
Drug shortages (35)
Duchenne muscular dystrophy (133)
Earnings (90364)
Editorial (45)
Employer branding (21)
Employer resources (154)
Events (119705)
Executive appointments (894)
FDA (18771)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (979)
Gene editing (144)
Generative AI (29)
Gene therapy (409)
GLP-1 (885)
Government (4747)
Grass and pollen (5)
Guidances (183)
Healthcare (19602)
HIV (42)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (169)
Immuno-oncology (11)
Indications (40)
Infectious disease (2931)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (64)
Intellectual property (122)
Interviews (355)
IPO (17160)
IRA (53)
Job creations (4203)
Job search strategy (1591)
Kidney cancer (14)
Labor market (53)
Layoffs (543)
Leadership (26)
Legal (8615)
Liver cancer (80)
Longevity (12)
Lung cancer (418)
Lymphoma (214)
Machine learning (11)
Management (61)
Manufacturing (429)
MASH (96)
Medical device (14038)
Medtech (14044)
Mergers & acquisitions (21065)
Metabolic disorders (928)
Multiple sclerosis (102)
NASH (20)
Neurodegenerative disease (130)
Neuropsychiatric disorders (38)
Neuroscience (2213)
NextGen: Class of 2025 (6914)
Non-profit (4631)
Now hiring (48)
Obesity (481)
Opinion (266)
Ovarian cancer (103)
Pain (121)
Pancreatic cancer (124)
Parkinson's disease (195)
Partnered (22)
Patents (317)
Patient recruitment (172)
Peanut (54)
People (60953)
Pharmaceutical (99)
Pharmacy benefit managers (25)
Phase I (21671)
Phase II (30527)
Phase III (22856)
Pipeline (1690)
Policy (230)
Postmarket research (2691)
Preclinical (9181)
Press Release (69)
Prostate cancer (146)
Psychedelics (38)
Radiopharmaceuticals (264)
Rare diseases (500)
Real estate (6465)
Recruiting (68)
Regulatory (24088)
Reports (50)
Research institute (2444)
Resumes & cover letters (382)
Rett syndrome (9)
RNA editing (10)
RSV (56)
Schizophrenia (95)
Series A (166)
Series B (116)
Service/supplier (18)
Sickle cell disease (64)
Special edition (21)
Spinal muscular atrophy (155)
Sponsored (36)
Startups (3844)
State (2)
Stomach cancer (16)
Supply chain (83)
Tariffs (66)
The Weekly (76)
Vaccines (829)
Venture capital (56)
Weight loss (316)
Women's health (48)
Worklife (18)
Date
Today (88)
Last 7 days (366)
Last 30 days (1888)
Last 365 days (32370)
2025 (17647)
2024 (36526)
2023 (41311)
2022 (52568)
2021 (57215)
2020 (55883)
2019 (48798)
2018 (36940)
2017 (34026)
2016 (33725)
2015 (39571)
2014 (33455)
2013 (28528)
2012 (30644)
2011 (31310)
2010 (29286)
Location
Africa (827)
Alabama (63)
Alaska (7)
Arizona (254)
Arkansas (14)
Asia (42766)
Australia (6761)
California (7590)
Canada (2400)
China (712)
Colorado (329)
Connecticut (326)
Delaware (200)
Europe (92382)
Florida (1151)
Georgia (261)
Hawaii (1)
Idaho (64)
Illinois (685)
India (29)
Indiana (378)
Iowa (18)
Japan (238)
Kansas (110)
Kentucky (31)
Louisiana (15)
Maine (64)
Maryland (1054)
Massachusetts (5717)
Michigan (268)
Minnesota (471)
Mississippi (3)
Missouri (100)
Montana (28)
Nebraska (25)
Nevada (84)
New Hampshire (67)
New Jersey (2134)
New Mexico (31)
New York (2136)
North Carolina (1153)
North Dakota (9)
Northern California (3319)
Ohio (247)
Oklahoma (17)
Oregon (40)
Pennsylvania (1635)
Puerto Rico (18)
Rhode Island (38)
South America (1216)
South Carolina (36)
South Dakota (1)
Southern California (2842)
Tennessee (129)
Texas (1161)
United States (28460)
Utah (227)
Virginia (203)
Washington D.C. (76)
Washington State (652)
West Virginia (4)
Wisconsin (80)
742,589 Results for "catalent pharma solutions inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharma & Vaccine Industry Leader Eddie Gray joins Botanical Solution Inc. (BSI) Board of Directors
June 23, 2025
·
3 min read
Venture capitalists
The Top 5 Most Active Corporate VCs in Pharma
BioSpace
examines the busiest corporate venture capital arms in the pharmaceutical industry. Novo Holdings, which made headlines last year with its $16.5 billion Catalent buy, topped the list.
May 21, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
Soligenix Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions
July 2, 2025
·
15 min read
Press Releases
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
July 15, 2025
·
13 min read
Press Releases
Prolific Machines Appoints Former Catalent Chief Scientific Officer to Board of Directors
May 15, 2025
·
3 min read
Press Releases
GenSight Biologics Announces Significant Milestone in New Manufacturing Partnership with Catalent
June 26, 2025
·
5 min read
Press Releases
IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025
April 28, 2025
·
2 min read
Editorial
Why It’s OK to Talk About Catalent’s Pending Buyout by ‘Novo’
The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of Catalent currently under FTC review—ultimately send proceeds to the Novo Nordisk Foundation, one of the world’s largest charitable foundations.
October 24, 2024
·
6 min read
·
Jef Akst
Deals
Revolution Establishes Endless Cash Runway With $2B Royalty Pharma Deal
In May, Revolution Medicines projected its cash and equivalents of $2.1 billion would last into the second half of 2027. With new funding from Royalty Pharma, the biotech has withdrawn that runway end date.
June 24, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Catalent Announces New Board Appointments
February 20, 2025
·
4 min read
1 of 74,259
Next